According to Gram Research analysis, taking folic acid supplements consistently after a hemorrhagic stroke may significantly reduce your risk of future heart disease and stroke. A 2026 prospective study of 799 stroke patients found that those who took their folic acid and blood pressure medication at least 70% of the time had an 84% lower risk of developing heart disease, a 79% lower risk of another stroke, and an 86% lower risk of death compared to those who took their medications less consistently.
A new study of 799 stroke patients found that taking folic acid along with a blood pressure medication significantly reduced their chances of having another stroke or heart attack. Researchers tracked patients for about 9.6 months and discovered that those who took their medications consistently had an 84% lower risk of developing heart disease compared to those who didn’t stick with the treatment. The findings suggest that folic acid supplementation might be an important tool for protecting stroke survivors from future cardiovascular problems, though more research is still needed to confirm these promising results.
Key Statistics
A 2026 prospective study of 799 stroke patients found that those with high medication adherence (≥70%) had an 84% lower risk of cardiovascular disease compared to those with low adherence (<70%), with a hazard ratio of 0.16.
Among 799 hemorrhagic stroke patients tracked for a median of 9.6 months, consistent use of folic acid and enalapril reduced the risk of recurrent hemorrhagic stroke by 79% (hazard ratio: 0.21) in the high-adherence group.
In a 2026 study of stroke survivors with elevated homocysteine levels, patients who consistently took their folic acid and blood pressure medication had an 86% lower risk of all-cause mortality compared to those with poor medication adherence.
During a 9.6-month follow-up period, only 5% of 799 stroke patients developed cardiovascular disease, with the lowest rates occurring in those who maintained high medication adherence (≥70%).
The Quick Take
- What they studied: Whether taking folic acid pills along with a blood pressure medication could prevent heart disease and second strokes in people who had already suffered a hemorrhagic stroke (bleeding in the brain).
- Who participated: 799 patients who had experienced a hemorrhagic stroke and had high blood pressure with elevated homocysteine levels (a protein in the blood linked to heart disease). Participants were tracked for about 9.6 months on average.
- Key finding: Patients who consistently took their folic acid and blood pressure medication (at least 70% of the time) had an 84% lower risk of developing heart disease, an 79% lower risk of having another stroke, and an 86% lower risk of dying from any cause compared to those who didn’t take their medications regularly.
- What it means for you: If you’ve had a stroke, taking folic acid supplements as prescribed by your doctor may significantly reduce your chances of having another stroke or heart attack. However, this benefit only works if you take the medication consistently. Talk to your doctor about whether this treatment is right for you.
The Research Details
This was a prospective study, which means researchers followed patients forward in time to see what happened to them. All 799 participants had experienced a hemorrhagic stroke (bleeding in the brain) and had a condition called H-type hypertension, which means they had high blood pressure combined with elevated homocysteine levels in their blood. Every participant received the same treatment: 10 mg of enalapril (a blood pressure medication) and 0.8 mg of folic acid (a B vitamin) daily.
Researchers divided patients into two groups based on how well they stuck to their medication schedule: those who took their pills at least 70% of the time (high adherence) and those who took them less than 70% of the time (low adherence). The study team then tracked both groups for a median of 9.6 months to see who developed heart disease, had another stroke, or died.
To make sure the results were fair, researchers used statistical methods to account for other factors that might affect outcomes, such as age, weight, cholesterol levels, and blood pressure readings. They also looked at whether the benefits of the medication differed for men versus women, younger versus older patients, and other subgroups.
This research approach is important because it shows real-world results in actual patients rather than just laboratory findings. By comparing people who took their medications consistently with those who didn’t, the study demonstrates that adherence—actually taking the pills as prescribed—makes a huge difference in outcomes. This helps doctors understand not just whether a treatment works, but whether patients need to be supported in taking it regularly to get the benefits.
This study has several strengths: it included a large number of patients (799), followed them over time to see actual outcomes, and used statistical methods to control for other factors that might affect results. However, the follow-up period was relatively short (about 9.6 months), and the study wasn’t a randomized controlled trial where some patients randomly received the treatment and others received a placebo. The authors themselves note that more rigorous trials are needed to confirm these findings.
What the Results Show
During the study period, 40 patients (5%) developed cardiovascular disease, and 21 patients (2.6%) had another hemorrhagic stroke. The key finding was that patients who took their medications consistently (at least 70% of the time) had dramatically better outcomes than those who didn’t stick with the treatment.
Specifically, patients with high medication adherence had an 84% lower risk of developing heart disease or having a heart attack compared to those with low adherence. This means that out of every 100 patients who took their medications consistently, only about 16 would be expected to develop heart disease, compared to about 100 in the low-adherence group (adjusted for the actual rates in the study).
The benefits extended beyond just heart disease. Patients who took their medications consistently also had a 79% lower risk of having another stroke and an 86% lower risk of dying from any cause during the study period. These reductions were statistically significant, meaning they’re unlikely to have happened by chance alone.
The study also examined whether the benefits of the treatment differed depending on patient characteristics. The protective effects of consistent medication use appeared across different subgroups, including men and women, younger and older patients, those with different weights, and those with different blood pressure and cholesterol levels. This suggests that the treatment may be beneficial for a wide range of stroke survivors, not just specific groups.
This research builds on earlier studies suggesting that elevated homocysteine levels increase the risk of heart disease and stroke. Folic acid is known to lower homocysteine levels, which is why researchers hypothesized it might help prevent future cardiovascular events in stroke survivors. This study provides some of the first evidence that combining folic acid with blood pressure medication in this specific patient population may actually reduce the risk of serious cardiovascular events. However, the authors note that previous large trials of folic acid supplementation have shown mixed results, so more research is needed.
Several limitations should be considered when interpreting these results. First, the study only followed patients for about 9.6 months on average, which is a relatively short time period. Second, this wasn’t a randomized controlled trial where patients were randomly assigned to receive either the treatment or a placebo—instead, all patients received the treatment, and researchers compared those who took it consistently with those who didn’t. This means that patients who took their medications consistently might have been different in other ways (such as being more health-conscious overall) that also contributed to better outcomes. Third, the study was conducted in a specific population (stroke patients with high homocysteine levels), so the results may not apply to all stroke survivors. Finally, the study was relatively small, with only 40 cardiovascular events occurring during the follow-up period, which limits the statistical power to detect differences.
The Bottom Line
For stroke survivors with high blood pressure and elevated homocysteine levels, taking folic acid supplementation along with blood pressure medication as prescribed by your doctor may significantly reduce your risk of future heart disease and stroke. The evidence is moderately strong based on this study, but doctors should note that more rigorous randomized controlled trials are needed to confirm these findings. Confidence level: Moderate—this is promising evidence, but not yet definitive.
This research is most relevant for people who have experienced a hemorrhagic stroke and have been diagnosed with H-type hypertension (high blood pressure with elevated homocysteine). If you fit this description, talk to your doctor about whether folic acid supplementation might be appropriate for you. The findings may also be relevant for other stroke survivors, though more research is needed. This research is less relevant for people without a history of stroke or those without elevated homocysteine levels.
Based on this study, the protective effects of consistent medication use appeared within the 9.6-month follow-up period. However, it’s important to understand that stroke prevention is a long-term commitment. You should expect to take these medications consistently for months and years to maintain the protective benefits. Talk to your doctor about realistic timelines for your specific situation.
Frequently Asked Questions
Can folic acid supplements prevent another stroke after you’ve had one?
Research shows that folic acid combined with blood pressure medication may reduce stroke risk by 79% in stroke survivors with elevated homocysteine levels, but only if taken consistently. A 2026 study of 799 patients found this benefit appeared in those taking medications at least 70% of the time.
How much folic acid should I take after a stroke?
The study used 0.8 mg of folic acid daily combined with blood pressure medication. However, the right dose for you depends on your individual health situation. Always follow your doctor’s specific recommendations rather than self-treating, as they’ll consider your medical history and other medications.
Does it matter if I miss doses of folic acid?
Yes, significantly. The 2026 study found that patients taking their medication at least 70% of the time had 84% lower heart disease risk, while those taking it less consistently had much higher risks. Consistency matters more than occasional perfect adherence.
Who should take folic acid after a stroke?
This research applies specifically to people with hemorrhagic stroke and elevated homocysteine levels. If you’ve had a stroke, ask your doctor whether folic acid supplementation is appropriate for your specific type of stroke and health profile, as benefits may vary.
How long do I need to take folic acid after a stroke?
The study followed patients for 9.6 months, but stroke prevention typically requires long-term treatment. Your doctor will determine how long you should continue folic acid based on your individual risk factors and recovery progress.
Want to Apply This Research?
- Set up a daily medication reminder in your app to take your folic acid and blood pressure medication at the same time each day. Track your adherence percentage weekly—aim for at least 70% consistency to match the ‘high adherence’ group in this study that saw the greatest benefits.
- Create a simple daily habit by taking your folic acid and blood pressure medication with breakfast or dinner every single day. Use your app to log each dose immediately after taking it, and review your adherence score weekly to stay motivated and accountable.
- Monitor your medication adherence percentage monthly through your app. Also track any cardiovascular symptoms (chest pain, shortness of breath, unusual fatigue) and report them to your doctor immediately. Schedule regular check-ins with your healthcare provider to discuss your adherence and any side effects you’re experiencing.
This article summarizes research findings and should not be interpreted as medical advice. Folic acid supplementation decisions should only be made in consultation with your healthcare provider, who can evaluate your individual medical history, current medications, and specific stroke type. The study results apply specifically to patients with hemorrhagic stroke and elevated homocysteine levels; benefits may differ for other populations. Do not start, stop, or change any medications without your doctor’s guidance. If you experience chest pain, shortness of breath, weakness, or other concerning symptoms, seek immediate medical attention.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.